Pulsenmore Ltd. (TLV:PULS)
Israel · Delayed Price · Currency is ILS · Price in ILA 389.40
+10.60 (2.80%)
Nov 6, 2025, 5:26 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 188.52 million as of November 7, 2025. Its market cap has decreased by -1.12% in one year.
Market Cap
188.52M
Enterprise Value
103.59M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
389.40
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 188.52M, a decrease of -76.29%. That is a compound annual growth rate of -27.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 202.06M | -19.69% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
| Jun 15, 2021 | 795.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 91.94B |
| Danel (Adir Yeoshua) | 2.80B |
| Kamada | 1.30B |
| SofWave Medical | 1.11B |
| Bait Bakfar | 1.09B |
| BrainsWay | 1.01B |
| Ilex Medical | 738.08M |
| Novolog (Pharm-Up 1966) | 623.27M |